Active04371441Private limited companyLeeds

NANOPHARM LIMITED

Significant control: Aptargroup UK Holdings Limited (75–100%)

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Nanopharm Limited: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Nanopharm Limited sell?

Registered activity: Manufacture of pharmaceutical preparations (SIC 21200). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01

Summary

Generated from filed data · no estimates

NANOPHARM LIMITED is an active private limited company (company number 04371441) incorporated on 11 February 2002, registered in Leeds. Its registered activity is manufacture of pharmaceutical preparations (SIC 21200). Latest medium accounts cover the period ending 31 December 2024, showing net assets of £1.77m and cash of £247k, with 76 employees on average. Turnover was £8.53m and profit for the year −£3.26m. Net assets fell 65% on the prior period (£5.02m).

Peer position · net assets

By net assets it sits in the top quarter of 307 comparable companies in the UK (median £1,000, upper quartile £146k).

02

Ownership and control

1 active · 5 other
  • Aptargroup Uk Holdings Limited
    corporate entity, England & Wales · since 5 June 2019
    • owns 75–100% of shares
    • holds 75–100% of voting rights
    • can appoint or remove directors
  • Dr Jagdeep Singh Shur
    Individual · since 6 April 2016 · ceased 5 June 2019
    • can appoint or remove directors
  • Sbms Enterprises Limited
    corporate entity, England And Wales · since 6 April 2016 · ceased 5 June 2019
    • owns 25–50% of shares
    • holds 25–50% of voting rights
  • Silures Limited
    corporate entity, Not Specified/Other · since 6 April 2016 · ceased 5 June 2019
    • owns 50–75% of shares
    • holds 50–75% of voting rights
    • can appoint or remove directors
  • Prof Robert Price
    Individual · since 6 April 2016 · ceased 5 June 2019
    • can appoint or remove directors
  • Mr Mark Rowland Clement
    Individual · since 6 April 2016 · ceased 6 April 2016
    • owns 25–50% of shares
    • holds 25–50% of voting rights

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

03

Key dates

Incorporated
11 February 200224 yrs ago
Next accounts due
30 September 202628 days overdue
Confirmation statement due
25 February 2027in 120 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

04

Activity

SIC 21200
Manufacture of pharmaceutical preparations
Accounts type
Medium
Size band
SmallCompanies Act thresholds
05

Financials

3 periods on record · latest ending 31 December 2024
Net assets
£1.77m
−65%vs Dec 2023
Cash at bank
£247k
+355%vs Dec 2023
Turnover
£8.53m
+14%vs Dec 2023
Employees
76
+3%vs Dec 2023
Net assets
£1.77m
Cash at bank
£247k
Turnover
£8.53m
Profit for the year
−£3.26m
Average employees
76
Filed accounts by period, newest first
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
31 December 2024£1.77m£247k£3.59m—£8.53m−£3.26m76
31 December 2023£5.02m£54k£3.16m—£7.49m−£712k74
31 December 2022———————
Net margin-38.2%Profit for the year ÷ turnover
Cash per employee£3,246Cash ÷ average employees

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

06

Filing and accounts signals

Facts from the register · no rating
  • Net assets above zeroNet assets £1,765,400 at 31 December 2024
  • Net assets down 25% or more on the prior period-64.8% vs prior period
  • Cash at bank of £50,000 or moreCash £246,713
  • Three or more accounting periods on record3 periods on record
  • Incorporated five or more years agoIncorporated 11 February 2002
  • Accounts past their due dateDue 30 September 2026

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

07

Timeline

Newest first
  1. Confirmation statement duein 120 days
  2. Next accounts due28 days overdue
  3. Accounts period endNet assets £1.77m · medium accounts
  4. Accounts period endNet assets £5.02m · medium accounts
  5. Accounts period end
  6. Incorporated
08

Similar companies in Leeds

Same activity (manufacture of pharmaceutical preparations), closest in incorporation date
09

Reminders for NANOPHARM LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31; accounts from the Companies House accounts data product. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown. Contact us about this company.